For example, this study only conducted pharmacological experiments and did not conduct in vivo knockdown or overexpression bidirectional validation of the intervention effect of Ori on TLR4/NF-κB/NLRP3 in esophageal cancer mice, as well as its downstream effects. This evidence concerns the gene NFKB1 and esophageal cancer.